导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.41% | 920/1050 |
| 近一周 | -4.63% | 1045/1104 |
| 近一月 | -4.45% | 550/1102 |
| 近一季 | -0.56% | 271/1092 |
| 近半年 | -12.31% | 825/1070 |
| 近一年 | -22.07% | 934/1018 |
| 近两年 | 0.96% | 881/926 |
| 近三年 | -32.33% | 816/834 |
| 成立以来 | 59.08% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.04% 861/1070 |
-14.82% 1015/1101 |
- - |
- - |
| 2025 | -5.49% 948/1065 |
0.66% 746/1014 |
-4.45% 944/1038 |
3.07% 964/1050 |
-4.66% 695/1065 |
| 2024 | -4.71% 696/1011 |
0.60% 282/960 |
-12.27% 915/983 |
14.47% 264/991 |
-5.68% 709/1011 |
| 2023 | -21.20% 697/952 |
2.38% 485/880 |
-13.76% 849/895 |
-2.25% 164/915 |
-8.71% 798/952 |
| 2022 | -11.89% 113/867 |
-21.65% 618/773 |
22.52% 9/806 |
-11.11% 309/845 |
3.25% 269/867 |
| 2021 | 5.60% 293/740 |
-6.29% 394/580 |
16.13% 221/659 |
-10.74% 529/704 |
8.72% 109/740 |
| 2020 | 95.73% 43/554 |
0.83% 143/419 |
26.50% 173/466 |
21.79% 41/517 |
26.00% 60/554 |
| 2019 | 56.45% 99/410 |
36.30% 119/1146 |
10.48% 9/1228 |
-0.64% 349/390 |
4.56% 353/410 |
| 2018 | -19.97% 80/349 |
- - |
11.25% 4/990 |
-7.01% 576/1000 |
-16.27% 924/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 银华食品饮料量化股票发起式C VS. 东吴新产业精选股票A(580008) |